While the role of CD81 displayed on CTCs is largely understudied, previous studies have used CD81+/CD56+/CD45− markers to detect neuroblastoma cells in the peripheral blood of patients (Nagai et al., 2000). This evidence concerns the gene NCAM1 and neuroblastoma.